Spero Therapeutics Inc Revenue per Employee (SPRO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Spero Therapeutics Inc   (NASDAQ: SPRO)
 

Spero Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Spero Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,879,880, but the productivity of Spero Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 23 other companies have achieved higher revenue per employee. While Spero Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 325 to 349. Spero Therapeutics Inc has 25 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SPRO Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - -95.61 % 174.51 % -59.6 % 39.15 %
Sales per Employee (TTM) $ 1,879,880 2,447,440 2,672,080 1,621,960 1,943,040
SPRO's Total Ranking # 349 # 325 # 903 # 1291 # 1073
Seq. Revenue Change - -99.38 % 658.86 % -61.65 % 141.56 %

SPRO Company Profile >> Back to SPRO Efficiency Comparisons >> Compare SPRO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 24
Overall Market # 349

Revenue per Employee Statistics
High Average Low
$ 4,738,400 $ 1,126,504 $ 52,840
(Jun 30 2024)   (Sep 30 2017)



Financial Statements
Spero Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit SPRO's Income Statement
Spero Therapeutics Inc 's Revenues TTM $ 47 Millions Visit SPRO's aggregate revenue growth
What are SPRO's Sales? Visit SPRO's Sales by Segment




Other Ratios
Spero Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SPRO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SPRO's Competitors
Revenue per Employee for SPRO's Suppliers
Revenue per Employee for SPRO's Customers

You may also want to know
SPRO's Sales Growth Rates SPRO's Pe Price to earnings ratio SPRO's Receivables Turnover Ratio SPRO's Stock Quote
SPRO's Net Income Growth Rates SPRO's Ps Price to Sales ratio SPRO's Sales per Employee SPRO's Asset Turnover Ratio
SPRO's Net Margin SPRO's Pb Price to Book ratio SPRO's Financial Strength Ratios SPRO's Dividend Payout Ratio
Date modified: 2026-09-03T17:21:24+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million 2 
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.